Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
02 Dezember 2022 - 4:41PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of
December 2022
Commission File Number: 001-31368
SANOFI
(Translation of
registrants name into English)
46, avenue de la Grande Armée, 75017 Paris, FRANCE
(Address of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ________
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ________
1
In November 2022, Sanofi published the press release attached hereto as Exhibit 99.1 which is incorporated
herein by reference.
Exhibit Index
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Dated: December 2, 2022 |
|
|
|
|
|
SANOFI |
|
|
|
|
|
|
|
|
By |
|
/s/ Alexandra
Roger
|
|
|
|
|
|
|
Name: Alexandra Roger |
|
|
|
|
|
|
Title: Head of Securities Law and Capital Markets |
3
Sanofi (PK) (USOTC:SNYNF)
Historical Stock Chart
Von Mär 2025 bis Apr 2025
Sanofi (PK) (USOTC:SNYNF)
Historical Stock Chart
Von Apr 2024 bis Apr 2025
Echtzeit-Nachrichten über Sanofi (PK) (OTCMarkets): 0 Nachrichtenartikel
Weitere Sanofi News-Artikel